Brain perfusion differences between Parkinson's disease and multiple system atrophy with predominant parkinsonian features

Parkinsonism and Related Disorders

Volumn 11, Issue 4, 2005, Pages 227-232

  Matsui, Hideaki ^a   Udaka, Fukashi ^a   Miyoshi, Takafumi ^a   Hara, Narihiro ^a   Tamura, Akiko ^a   Oda, Masaya ^a   Kubori, Tamotsu ^a   Nishinaka, Kazuto ^a   Kameyama, Masakuni ^a  

^a SUMITOMO HOSPITAL   (Japan)

Author keywords

Multiple system atrophy with predominant parkinsonian features; N isopropyl P 123I iodoamphetamine (123I IMP) SPECT; Parkinson's disease; Three dimensional stereotactic surface projections (3D SSP)

Indexed keywords

IOFETAMINE I 123;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CEREBELLUM; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCIPITAL LOBE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PUTAMEN; SENSORIMOTOR CORTEX; SHY DRAGER SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CEREBROVASCULAR CIRCULATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 18844443748     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2005.01.001     Document Type: Article

References (20)

1. S. Minoshima, K.A. Frey, R.A. Koeppe, N.L. Foster, and D.E. Kuhl A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET J Nucl Med 36 1995 1238 1248
2. K.J. Friston Analyzing brain images: principles and overview R.S.J. Frackowiak K.J. Friston C.D. Frith R.J. Dolan J.C. Mazziotta Human brain function 1997 Academic Press San Diego 25 41
3. A.J. Hughes, S.E. Daniel, L. Kilford, and A.J. Lees Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 1992 181 184
4. S. Gilman, P.A. Low, N. Quinn, A. Albanese, Y. Ben-Shlomo, C.J. Fowler, H. Kaufmann, T. Klockgether, A.E. Lang, P.L. Lantos, I. Litvan, C.J. Mathias, E. Oliver, D. Robertson, I. Schatz, and G.K. Wenning Consensus statement on the diagnosis of multiple system atrophy J Neurol Sci 163 1999 94 98
5. S. Minoshima, B. Giordani, S. Berent, K.A. Frey, N.L. Foster, and D.E. Kuhl Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease Ann Neurol 42 1997 85 94
6. K.J. Worsley, S. Marrett, P. Neelin, A.C. Vandal, K.J. Friston, and A.C. Evans A unified statistical approach for determining significant signals in location and scale space images of cerebral activation R. Myers V. Cunningham D. Baily T. Jones Quantification of brain function using PET 1996 Academic Press San Diego 327 333
7. H. Kageyama, S. kikuchi, and K. Tashiro Analysis of Parkinson's disease and related syndromes using 123I-IMP-SPECT with the ARG method Nihonrinsho 55 1997 238 242
8. H. Hayashi, I. Odano, M. Nishihara, S. Higuchi, K. Sakai, and A. Ishikawa Clinical evaluation of Parkinson's disease using 123I-IMP SPECT Kakuigaku 26 1989 1405 1415
9. H. Kamei, T. Nakajima, and N. Fukuhara Statistic rCBF study of extrapyramidal disorders No To Shinkei 54 2002 667 672
10. A. Kikuchi, A. Takeda, T. Kimpara, M. Nakagawa, R. Kawashima, M. Sugiura, S. Kinomura, H. Fukuda, K. Chida, N. Okita, S. Takase, and Y. Itoyama Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease J Neurol Sci 193 2001 29 36
11. A. Feigin, A. Antonini, M. Fukada, R.D. Notaris, R. Benti, G. Pezzolo, M. Mentis, J.R. Moeller, and D. Eidelberg Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism Mov Disord 17 2002 1265 1270
12. Y. Imon, H. Matsuda, M. Ogawa, D. Kogure, and N. Sunohara SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease J Nucl Med 40 1999 1583 1589
13. T. Bosman, K. Van Laere, and P. Santens Anatomically standardised 99mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson's disease Eur J Nucl Med 30 2003 16 24
14. K. Van Laere, P. Santens, T. Bosman, J.D. Reuck, L. Mortelmans, and R. Dierckx Statistical parametric mapping of 99mTc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkisonian features: correlations with clinical parameters J Nucl Med 45 2004 933 942
15. N.I. Bohnen, S. Minoshima, B. Giordani, K.A. Frey, and D.E. Kuhl Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia Neurology 52 1999 541 546
16. S. Vander Borght Tm Minoshima, B. Giordani, N.L. Foster, K.A. Frey, S. Berent, R.L. Albin, R.A. Koeppe, and D.E. Kuhl Cerebral metabolic differences in Parkinson's disease and Alzheimer's disease matched for dementia severity J Nucl Med 38 1997 797 802
17. D. Eidelberg, and C. Edwards Functional brain imaging of movement disorders Neurol Res 22 2000 305 312
18. A. Antonini, K.L. Leenders, P. Vontobel, R.P. Maguire, J. Missimer, M. Psylla, and I. Gunther Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease Brain 120 1997 2187 2195
19. T. Taniwaki, M. Nakagawa, T. Yamada, T. Yoshida, Y. Ohyagi, M. Sasaki, Y. Kuwabara, S. Tobimatsu, and J. Kira Cerebral metabolic changes in early multiple system atrophy: a PET study J Neurol Sci 200 2002 79 84
20. S. Gilman Biochemical changes in multiple system atrophy detected with positron emission tomography Parkinsonism Relat Disord 7 2001 253 256